SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.830-17.5%Dec 29 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brent J. Sheets who wrote (3221)12/3/1996 9:43:00 AM
From: gbull   of 14328
 
Brent:

Trinity expects to market its tests to POC (point of contact) market. This simplifies the submittal process and also regulatory process. I heartily agree as a first step. It is tough to see someone else getting money for a product. Wonder what their marketing and advertising is costing them? Reminds me of K-tel products. Lots of schtick but really doubt whether they are capable or even interested in penetrating major medical markets with innovative testing approach comparable to Trinity.

Liked the biotech article but is Trinity really biotech? I believe the real market is in dropping the testing process costs for all sorts of diagnosis. That's why the Uni-Gold platform is a valuable (work in progress it seems) asset to shareholders. It can support a wide variety of tests using the same technology. I can see cases and cases of these tests in POC doctors offices for instantaneous testing whereas presently they draw blood, send it to the lab, receive results, contact the patient and begin treatment if necessary. Instantaneous testing will dramatically lower the overhead and direct costs to these doctors, HMO's, or whatever entity is running costs and treatment.

To All:

Has the Uni-gold platform been submitted for use for any test?

Patiently but with doubts and fears:

The MooseMan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext